TM6SF1
Transmembrane 6 superfamily member 1
Also known as: TM6S1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BZW5
- Gene
- TM6SF1
- Ensembl
- ENSG00000136404
- Chromosome
- 15
- Canonical length
- 370 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
Predicted to be located in lysosome and membrane. Predicted to be active in lysosomal membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
370 residues, UniProt reviewed canonical sequence.
>Q9BZW5|TM6SF1
1 MSASAATGVF VLSLSAIPVT YVFNHLAAQH DSWTIVGVAA LILFLVALLA RVLVKRKPPR
61 DPLFYVYAVF GFTSVVNLII GLEQDGIIDG FMTHYLREGE PYLNTAYGHM ICYWDGSAHY
121 LMYLVMVAAI AWEETYRTIG LYWVGSIIMS VVVFVPGNIV GKYGTRICPA FFLSIPYTCL
181 PVWAGFRIYN QPSENYNYPS KVIQEAQAKD LLRRPFDLML VVCLLLATGF CLFRGLIALD
241 CPSELCRLYT QFQEPYLKDP AAYPKIQMLA YMFYSVPYFV TALYGLVVPG CSWMPDITLI
301 HAGGLAQAQF SHIGASLHAR TAYVYRVPEE AKILFLALNI AYGVLPQLLA YRCIYKPEFF
361 IKTKAEEKVELocalizationUniProt · AlphaFold · HPA
Whether an antibody against TM6SF1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 9
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 44 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 44 nTPM
- tongue: 20 nTPM
- lung: 10 nTPM
- cerebral cortex: 9.9 nTPM
- thyroid gland: 9.7 nTPM
- heart muscle: 8.9 nTPM
Single-cell type
- microglia: 216 nCPM
- neutrophils: 115 nCPM
- megakaryocytes: 105 nCPM
- macrophages: 90 nCPM
- myonuclei: 89 nCPM
- neutrophil progenitors: 85 nCPM
Immune cell
- eosinophil: 196 nTPM
- neutrophil: 119 nTPM
- basophil: 77 nTPM
- classical monocyte: 32 nTPM
- myeloid DC: 19 nTPM
- intermediate monocyte: 14 nTPM
Brain region
- cerebellum: 16 nTPM
- white matter: 16 nTPM
- spinal cord: 15 nTPM
- medulla oblongata: 14 nTPM
- pons: 14 nTPM
- choroid plexus: 13 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.05
- gnomAD pLI
- 0
- gnomAD missense Z
- 1
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TM6SF1 as an antibody target. Whether an autoantibody or antibody against TM6SF1 could matter depends on whether native TM6SF1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TM6SF1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TM6SF1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...